https://news.medxy.ai/zh/masld-diagnosis-advances/Medxy AIzh2026-11-06T03:21:01-08:00MASLD诊断再升级：LITMUS多中心研究揭示无创检测新进展 https://news.medxy.ai/ja/advancing-masld-diagnosis/Medxy AIja2026-11-06T03:20:36-08:00MASLD診断を前進させる――LITMUS多施設研究が示した新たな知見 https://news.medxy.ai/vi/advancing-masld-diagnosis-litmus/Medxy AIvi2026-11-06T03:20:13-08:00Thúc đẩy chẩn đoán MASLD – Những phát hiện mới từ nghiên cứu đa trung tâm LITMUS https://news.medxy.ai/advancing-diagnosis-in-metabolic-dysfunction-associated-steatotic-liver-disease-insights-from-the-litmus-multicentre-study/Medxy AIen2026-11-06T03:19:53-08:00Advancing Diagnosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from the LITMUS Multicentre Study https://news.medxy.ai/zh/reducing-acute-care-use-picu/Medxy AIzh2026-11-06T03:19:14-08:00减少PICU出院后急性期医疗利用的关键——早期初级保健随访的有效性 https://news.medxy.ai/ja/reducing-acute-care-use/Medxy AIja2026-11-06T03:18:57-08:00PICU退室後の急性期医療利用を減らす鍵──早期プライマリケアフォローアップの有効性 https://news.medxy.ai/vi/reduced-acute-care-use/Medxy AIvi2026-11-06T03:18:34-08:00Giảm sử dụng chăm sóc cấp tính sau PICU nhờ theo dõi chăm sóc ban đầu sớm: Bằng chứng từ các ca nhập viện nhi khoa https://news.medxy.ai/reducing-post-picu-acute-care-through-early-primary-care-follow-up-evidence-from-pediatric-hospitalizations/Medxy AIen2026-11-06T03:18:16-08:00Reducing Post-PICU Acute Care through Early Primary Care Follow-Up: Evidence from Pediatric Hospitalizations https://news.medxy.ai/zh/il-4-receptor-scleroderma/Medxy AIzh2026-11-06T03:17:34-08:00靶向局限性硬皮病中的 IL-4 受体α：2期研究提示纤维化调控前景 https://news.medxy.ai/ja/il-4-receptor-localized-scleroderma/Medxy AIja2026-11-06T03:17:14-08:00限局性強皮症におけるIL-4受容体αを標的化：第2相試験が線維化制御の可能性を示唆 https://news.medxy.ai/vi/il-4ra-localized-scleroderma/Medxy AIvi2026-11-06T03:16:54-08:00Nhắm vào IL-4Rα trong xơ cứng bì khu trú: bằng chứng giai đoạn 2 đầy hứa hẹn cho điều biến xơ hóa https://news.medxy.ai/il-4-scleroderma-fibrosis/Medxy AIen2026-11-06T03:16:35-08:00Targeting IL-4 Receptor-α in Localised Scleroderma: Promising Phase 2 Evidence for Fibrosis Modulation https://news.medxy.ai/zh/improving-uterus-transplant-outcomes/Medxy AIzh2026-11-06T03:15:58-08:00优化子宫移植结局：达拉斯项目的活体供者全面评估 https://news.medxy.ai/ja/improving-uterus-transplant-outcomes-2/Medxy AIja2026-11-06T03:15:36-08:00子宮移植の成績を高めるには：ダラスプログラムに学ぶ生活ドナー評価の全貌 https://news.medxy.ai/vi/uterine-transplant-outcomes/Medxy AIvi2026-11-06T03:15:14-08:00Tối ưu hóa kết quả ghép tử cung: Đánh giá toàn diện người hiến sống từ Chương trình Dallas https://news.medxy.ai/optimizing-outcomes-in-uterus-transplantation-comprehensive-living-donor-evaluation-from-the-dallas-program/Medxy AIen2026-11-06T03:14:58-08:00Optimizing Outcomes in Uterus Transplantation: Comprehensive Living Donor Evaluation from the Dallas Program https://news.medxy.ai/zh/systemic-sclerosis-risk-assessment/Medxy AIzh2026-11-06T03:14:20-08:00系统性硬化症新分层：从血管与纤维化并发症看风险评估 https://news.medxy.ai/ja/systemic-sclerosis-risk-stratification/Medxy AIja2026-11-06T03:13:59-08:00全身性強皮症を読み解く：血管‐線維化に基づく新たなリスク層別化フレームワーク https://news.medxy.ai/vi/systemic-sclerosis-risk-stratification-2/Medxy AIvi2026-11-06T03:13:37-08:00Giải mã xơ cứng bì toàn thân: khung phân tầng mới dựa trên mạch máu và xơ hóa để đánh giá nguy cơ https://news.medxy.ai/decoding-systemic-sclerosis-a-new-vascular-fibrotic-framework-for-risk-stratification/Medxy AIen2026-11-06T03:13:20-08:00Decoding Systemic Sclerosis: A New Vascular-Fibrotic Framework for Risk Stratification https://news.medxy.ai/zh/optimizing-tissue-expansion-timing/Medxy AIzh2026-11-06T03:12:40-08:00借助3D扫描预测模型优化组织扩张手术时机 https://news.medxy.ai/ja/predicting-optimal-surgery-timing/Medxy AIja2026-11-06T03:12:18-08:003Dスキャンで組織拡張の手術時期を最適化する予測モデル https://news.medxy.ai/vi/optimal-surgery-timing-in-skin-expansion/Medxy AIvi2026-11-06T03:11:52-08:00Tối ưu thời điểm phẫu thuật trong giãn da bằng mô hình dự đoán dựa trên quét 3D https://news.medxy.ai/enhancing-surgical-timing-in-tissue-expansion-with-3d-scanning-based-predictive-modeling/Medxy AIen2026-11-06T03:11:34-08:00Enhancing Surgical Timing in Tissue Expansion with 3D Scanning-Based Predictive Modeling https://news.medxy.ai/zh/mindfulness-opioid-recovery/Medxy AIzh2026-11-06T03:10:49-08:00正念导向康复增强如何重塑阿片类物质使用障碍的前额叶皮层：来自随机对照试验的神经生物学与临床启示 https://news.medxy.ai/ja/mindfulness-opioid-use-disorder/Medxy AIja2026-11-06T03:10:22-08:00オピオイド使用障害におけるマインドフルネス介入による前頭前野皮質の再編成――ランダム化比較試験からみた神経生物学的・臨床的示唆 https://news.medxy.ai/vi/mindfulness-opioid-use-disorder-recovery/Medxy AIvi2026-11-06T03:09:54-08:00Quá trình phục hồi dựa trên chánh niệm có thể tái định hình vỏ não trước trán ở những người mắc chứng rối loạn sử dụng opioid https://news.medxy.ai/prefrontal-cortical-remodeling-via-mindfulness-oriented-recovery-enhancement-in-opioid-use-disorder-neurobiological-and-clinical-insights-from-a-randomized-controlled-trial/Medxy AIen2026-11-06T03:09:34-08:00Prefrontal Cortical Remodeling via Mindfulness-Oriented Recovery Enhancement in Opioid Use Disorder: Neurobiological and Clinical Insights from a Randomized Controlled Trial https://news.medxy.ai/zh/early-antifungal-treatment-shock-outcomes/Medxy AIzh2026-11-06T03:08:39-08:00抓住黄金时间：尽早启动抗真菌治疗可显著改善念珠菌性脓毒性休克结局 https://news.medxy.ai/vi/timely-antifungal-treatment-candidiasis-shock/Medxy AIvi2026-11-06T03:08:00-08:00Khởi trị kháng nấm kịp thời là yếu tố quyết định cải thiện tiên lượng trong sốc nhiễm Candida https://news.medxy.ai/timely-antifungal-therapy-initiation-is-crucial-in-improving-outcomes-in-candida-septic-shock/Medxy AIen2026-11-06T03:07:44-08:00Timely Antifungal Therapy Initiation Is Crucial in Improving Outcomes in Candida Septic Shock https://news.medxy.ai/zh/ambient-ai-medical-scribes/Medxy AIzh2026-11-06T03:07:03-08:00环境式 AI 记录员在急诊医师中的应用：多中心证据综合显示可减轻文书负担 https://news.medxy.ai/ja/ambient-ai-scribes-in-emergency-medicine/Medxy AIja2026-11-06T03:06:41-08:00急诊医师中的环境型AI书记员：文书效率与临床影响的多中心证据综述 https://news.medxy.ai/vi/ambient-ai-scribe-emergency-doctors/Medxy AIvi2026-11-06T03:06:14-08:00Sử dụng Ambient AI Scribe giúp giảm gánh nặng ghi chép ở bác sĩ cấp cứu: Tổng hợp bằng chứng đa trung tâm https://news.medxy.ai/ambient-artificial-intelligence-scribe-use-and-objective-documentation-effort-among-emergency-physicians-a-multisite-evidence-synthesis/Medxy AIen2026-11-06T03:05:48-08:00Ambient Artificial Intelligence Scribe Use and Objective Documentation Effort Among Emergency Physicians: A Multisite Evidence Synthesis https://news.medxy.ai/ja/discharge-language-preferences/Medxy AIja2026-11-06T03:04:36-08:00退院時コミュニケーションの選好を探る離散選択実験――英語以外を希望する患者を対象に https://news.medxy.ai/vi/discharge-preferences-experiment/Medxy AIvi2026-11-06T03:04:15-08:00Khám phá ưu tiên xuất viện của người bệnh có ngôn ngữ ưu tiên không phải tiếng Anh bằng thí nghiệm lựa chọn rời rạc https://news.medxy.ai/a-discrete-choice-experiment-to-understand-hospital-discharge-preferences-of-populations-with-non-english-language-preference/Medxy AIen2026-11-06T03:03:59-08:00A Discrete Choice Experiment to Understand Hospital Discharge Preferences of Populations with Non-English Language Preference https://news.medxy.ai/ja/2-fucosyllactose-in-stem-cell-transplantation-immunity/Medxy AIja2026-11-06T03:03:00-08:002′-フコシルラクトース：小児同種造血幹細胞移植における腸内細菌叢および免疫学的転帰を調節するための新たな戦略 https://news.medxy.ai/vi/fucosyllactose-after-transplantation/Medxy AIvi2026-11-06T03:02:39-08:002′-Fucosyllactose (2′-FL) trong sữa mẹ: điều biến hệ vi sinh đường ruột và đáp ứng miễn dịch sau ghép tế bào gốc tạo máu dị sinh ở trẻ em https://news.medxy.ai/human-milk-oligosaccharide-2-fucosyllactose-2-fl-as-a-modulator-of-gut-microbiome-and-immune-outcomes-in-pediatric-allogeneic-hematopoietic-stem-cell-transplantation/Medxy AIen2026-11-06T03:02:19-08:00Human Milk Oligosaccharide 2′-Fucosyllactose (2′-FL) as a Modulator of Gut Microbiome and Immune Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation https://news.medxy.ai/zh/weight-loss-intervention-effects-for-sleep-apnea/Medxy AIzh2026-11-06T03:01:30-08:00自主减重对阻塞性睡眠呼吸暂停的干预效果：POWER试验 https://news.medxy.ai/ja/weight-loss-intervention-effects/Medxy AIja2026-11-06T03:01:10-08:00閉塞性睡眠時無呼吸における自己主導型減量介入の効果を検証：POWER試験から見えたこと https://news.medxy.ai/vi/sleep-apnea-weight-loss/Medxy AIvi2026-11-06T03:00:47-08:00Ngưng thở khi ngủ do tắc nghẽn và giảm cân: bài học từ thử nghiệm POWER https://news.medxy.ai/evaluating-the-impact-of-a-self-directed-weight-loss-intervention-in-obstructive-sleep-apnea-insights-from-the-power-trial/Medxy AIen2026-11-06T03:00:28-08:00Evaluating the Impact of a Self-Directed Weight Loss Intervention in Obstructive Sleep Apnea: Insights from the POWER Trial https://news.medxy.ai/zh/eye-screening-in-tamoxifen-treatment/Medxy AIzh2026-11-06T02:59:45-08:00他莫昔芬相关眼科并发症：临床启示、筛查现状及视网膜毒性风险 https://news.medxy.ai/ja/eye-screening-tamoxifen-toxicities/Medxy AIja2026-11-06T02:59:19-08:00タモキシフェン開始後の眼科受診：臨床的示唆、スクリーニング実態、網膜毒性リスク https://news.medxy.ai/vi/eye-screening-for-tamoxifen-toxicities/Medxy AIvi2026-11-06T02:58:50-08:00Khám nhãn khoa sau khi bắt đầu dùng tamoxifen: Các gợi ý lâm sàng, thực trạng sàng lọc và nguy cơ gây độc cho võng mạc https://news.medxy.ai/ophthalmic-encounters-after-tamoxifen-initiation-clinical-insights-screening-practices-and-retinal-toxicity-risks/Medxy AIen2026-11-06T02:58:24-08:00Ophthalmic Encounters After Tamoxifen Initiation: Clinical Insights, Screening Practices, and Retinal Toxicity Risks https://news.medxy.ai/zh/vestibular-migraine-auditory-processing/Medxy AIzh2026-11-06T02:57:27-08:00前庭性偏头痛的选择性听觉时间处理缺陷：研究发现与临床启示 https://news.medxy.ai/ja/selective-auditory-processing-deficits/Medxy AIja2026-11-06T02:57:05-08:00前庭性片頭痛における選択的な聴覚時間処理障害：新たな知見と臨床的示唆 https://news.medxy.ai/vi/selective-auditory-processing-deficit/Medxy AIvi2026-11-06T02:56:42-08:00Suy giảm xử lý thời gian thính giác có chọn lọc trong migraine tiền đình: phát hiện và ý nghĩa lâm sàng https://news.medxy.ai/selective-auditory-temporal-processing-deficits-in-vestibular-migraine-insights-and-implications/Medxy AIen2026-11-06T02:56:26-08:00Selective Auditory Temporal Processing Deficits in Vestibular Migraine: Insights and Implications https://news.medxy.ai/zh/medical-debt-disparities/Medxy AIzh2026-11-06T02:55:49-08:00创伤后医疗债务为何差异悬殊？一项全州队列研究揭示医院层面的关键影响 https://news.medxy.ai/ja/hospital-medical-debt-disparities/Medxy AIja2026-11-06T02:55:27-08:00外傷後の医療債務にみる病院間格差を読み解く：州全体コホート研究からの示唆 https://news.medxy.ai/vi/medical-debt-after-injury/Medxy AIvi2026-11-06T02:55:06-08:00Giải mã sự khác biệt giữa các bệnh viện về nợ y tế sau chấn thương: Góc nhìn từ một nghiên cứu đoàn hệ toàn bang https://news.medxy.ai/unraveling-hospital-level-differences-in-medical-debt-post-trauma-insights-from-a-statewide-cohort-study/Medxy AIen2026-11-06T02:54:50-08:00Unraveling Hospital-Level Differences in Medical Debt Post-Trauma: Insights from a Statewide Cohort Study https://news.medxy.ai/zh/menopause-hormone-trajectories/Medxy AIzh2026-11-06T02:54:09-08:00解读绝经期抗缪勒管激素轨迹：对心血管健康的启示 https://news.medxy.ai/ja/understanding-amh-changes-menopause/Medxy AIja2026-11-06T02:53:51-08:00閉経期のAMH変動を読み解く：心血管健康への示唆 https://news.medxy.ai/vi/anti-mullerian-hormone-menopause-2/Medxy AIvi2026-11-06T02:53:30-08:00Giải mã quỹ đạo anti-müllerian hormone trong thời kỳ mãn kinh: Ý nghĩa đối với sức khỏe tim mạch https://news.medxy.ai/anti-mullerian-hormone-menopause/Medxy AIen2026-11-06T02:53:14-08:00Decoding Anti-Müllerian Hormone Trajectories During Menopause: Implications for Cardiovascular Health https://news.medxy.ai/zh/targeting-myofibroblast-derived-transglutaminase-2/Medxy AIzh2026-11-06T02:52:33-08:00靶向肌成纤维细胞来源的转谷氨酰胺酶2：狭窄型克罗恩病肠纤维化治疗的新路径 https://news.medxy.ai/ja/targeting-myofibroblast-derived-transglutaminase-2-in-colon-disease/Medxy AIja2026-11-06T02:52:11-08:00筋線維芽細胞由来のトランスグルタミナーゼ2を標的とする：狭窄型クローン病における腸管線維化治療の新たなアプローチ https://news.medxy.ai/vi/targeting-transglutaminase-2/Medxy AIvi2026-11-06T02:51:44-08:00Nhắm trúng Transglutaminase 2 có nguồn gốc từ nguyên bào sợi cơ: hướng điều trị mới cho xơ hóa ruột trong bệnh Crohn thể hẹp https://news.medxy.ai/targeting-myofibroblast-derived-transglutaminase-2-a-novel-therapeutic-avenue-for-intestinal-fibrosis-in-stricturing-crohns-disease/Medxy AIen2026-11-06T02:51:25-08:00Targeting Myofibroblast-Derived Transglutaminase 2: A Novel Therapeutic Avenue for Intestinal Fibrosis in Stricturing Crohn’s Disease https://news.medxy.ai/zh/mri-arteriovenous-shunt-detection/Medxy AIzh2026-11-06T02:46:43-08:00MRI 动脉自旋标记无创排除脑实质内出血中的动静脉分流：一项前瞻性多中心研究的启示 https://news.medxy.ai/ja/noninvasive-arteriovenous-shunt-exclusion/Medxy AIja2026-11-06T02:46:12-08:00MRI動脈スピンラベリングで脳内出血の動静脈短絡を非侵襲的に除外　前向き多施設研究が示す新知見 https://news.medxy.ai/vi/noninvasive-arteriovenous-shunt-exclusion-mri/Medxy AIvi2026-11-06T02:45:44-08:00Kỹ thuật ghi hình cộng hưởng từ gắn nhãn spin động mạch (MRI arterial spin labeling) có thể loại trừ tình trạng thông động tĩnh mạch một cách không xâm lấn trong các trường hợp xuất huyết trong nhu mô https://news.medxy.ai/noninvasive-exclusion-of-arteriovenous-shunts-in-intracerebral-hemorrhage-using-mri-arterial-spin-labeling-insights-from-a-prospective-multicenter-study/Medxy AIen2026-11-06T02:45:21-08:00Noninvasive Exclusion of Arteriovenous Shunts in Intracerebral Hemorrhage Using MRI Arterial Spin Labeling: Insights from a Prospective Multicenter Study https://news.medxy.ai/zh/sunitinib-pheochromocytoma-paraganglioma/Medxy AIzh2026-11-06T02:44:40-08:00舒尼替尼治疗晚期及转移性嗜铬细胞瘤/副神经节瘤：前瞻性试验证据下的疗效、安全性与临床意义 https://news.medxy.ai/ja/sunitinib-pheochromocytoma-paraganglioma-3/Medxy AIja2026-11-06T02:44:18-08:00進行性・転移性褐色細胞腫／傍神経節腫に対するスニチニブの評価：前向き試験からみた有効性・安全性・臨床的意義 https://news.medxy.ai/vi/sunitinib-pheochromocytoma-paraganglioma-2/Medxy AIvi2026-11-06T02:43:49-08:00Sunitinib trong pheochromocytoma và paraganglioma tiến triển/di căn: Hiệu quả, độ an toàn và ý nghĩa lâm sàng từ các thử nghiệm tiến cứu https://news.medxy.ai/evaluating-sunitinib-for-advanced-and-metastatic-pheochromocytomas-and-paragangliomas-efficacy-safety-and-clinical-implications-from-prospective-trials/Medxy AIen2026-11-06T02:43:23-08:00Evaluating Sunitinib for Advanced and Metastatic Pheochromocytomas and Paragangliomas: Efficacy, Safety, and Clinical Implications from Prospective Trials https://news.medxy.ai/zh/resistance-training-aerobic-exercise/Medxy AIzh2026-11-06T02:42:42-08:00抗阻训练叠加有氧运动与减少久坐，可显著降低美国女性心血管风险 https://news.medxy.ai/ja/cardiovascular-risk-reduction/Medxy AIja2026-11-06T02:42:16-08:00有酸素運動と座位時間の見直しで、米国女性の心血管リスクが大きく低下 https://news.medxy.ai/vi/resistance-training-aerobic-exercise-reduced-cardiovascular-risk/Medxy AIvi2026-11-06T02:41:47-08:00Việc kết hợp tập luyện kháng lực với các bài tập aerobic, đồng thời giảm bớt lối sống ít vận động, có thể giúp phụ nữ Mỹ giảm đáng kể nguy cơ mắc các bệnh tim mạch https://news.medxy.ai/integrated-resistance-training-aerobic-exercise-and-sedentary-behavior-reduction-significantly-lower-cardiovascular-risk-in-u-s-women/Medxy AIen2026-11-06T02:41:23-08:00Integrated Resistance Training, Aerobic Exercise, and Sedentary Behavior Reduction Significantly Lower Cardiovascular Risk in U.S. Women https://news.medxy.ai/zh/consolidation-therapy-lung-cancer/Medxy AIzh2026-11-06T02:40:41-08:00放化疗后不可切除Ⅲ期非小细胞肺癌巩固治疗：benmelstobart 联用或不联用 anlotinib 的 R-ALPS 试验解读 https://news.medxy.ai/ja/benmelstobart-consolidation-nsclc/Medxy AIja2026-11-06T02:40:10-08:00切除不能III期NSCLCの化学放射線療法後地固め療法としてのベンメルストバート単独またはアントロチニブ併用の評価：R-ALPS試験からの知見 https://news.medxy.ai/vi/benmelstobart-consolidation-therapy-for-nsclc/Medxy AIvi2026-11-06T02:39:45-08:00Hiệu quả của anlotinib (kèm hoặc không kèm các tác nhân khác) như liệu pháp củng cố đối với ung thư phổi không tế bào nhỏ giai đoạn III không thể phẫu thuật sau xạ trị https://news.medxy.ai/evaluating-benmelstobart-with-or-without-anlotinib-as-consolidation-therapy-after-chemoradiotherapy-in-unresectable-stage-iii-nsclc-insights-from-the-r-alps-trial/Medxy AIen2026-11-06T02:39:22-08:00Evaluating Benmelstobart With or Without Anlotinib as Consolidation Therapy After Chemoradiotherapy in Unresectable Stage III NSCLC: Insights from the R-ALPS Trial https://news.medxy.ai/zh/college-pitching-workload-velocity-injury-risk/Medxy AIzh2026-11-06T02:38:33-08:00大学棒球投手投球负荷与球速波动：手臂损伤风险的新线索 https://news.medxy.ai/ja/pitch-count-arm-injury-risk/Medxy AIja2026-11-06T02:38:11-08:00大学野球投手における投球数と球速の変化が腕の障害リスクを左右する https://news.medxy.ai/vi/pitch-count-velocity-arm-injuries/Medxy AIvi2026-11-06T02:37:41-08:00Số lần ném và vận tốc ném thay đổi ra sao liên quan đến chấn thương tay ở vận động viên ném bóng chày đại học? https://news.medxy.ai/dynamic-pitch-count-and-velocity-changes-linked-to-arm-injuries-in-collegiate-baseball-pitchers/Medxy AIen2026-11-06T02:37:19-08:00Dynamic Pitch Count and Velocity Changes Linked to Arm Injuries in Collegiate Baseball Pitchers https://news.medxy.ai/zh/robot-detects-thumb-sensory-loss/Medxy AIzh2026-11-06T02:36:41-08:00机器人评估新发现：卒中后拇指本体感觉缺损更常见 https://news.medxy.ai/ja/robot-visualizes-thumb-sensation-impairment/Medxy AIja2026-11-06T02:36:23-08:00脳卒中後に見逃されがちな母指固有感覚障害をロボットが可視化 https://news.medxy.ai/vi/advanced-robot-thumb-proprioception-deficits/Medxy AIvi2026-11-06T02:35:55-08:00Đánh giá robot tiên tiến hé lộ thiếu hụt cảm giác bản thể ngón cái thường gặp sau đột quỵ https://news.medxy.ai/innovative-robotic-assessment-unveils-prevalent-thumb-proprioceptive-deficits-post-stroke/Medxy AIen2026-11-06T02:35:30-08:00Innovative Robotic Assessment Unveils Prevalent Thumb Proprioceptive Deficits Post-Stroke https://news.medxy.ai/zh/interpretable-periodontitis-severity-model/Medxy AIzh2026-11-06T02:34:51-08:00基于常规血液生物标志物的牙周炎严重程度可解释机器学习分层模型 https://news.medxy.ai/ja/interpretable-periodontitis-model/Medxy AIja2026-11-06T02:34:22-08:00日常血液バイオマーカーで歯周炎重症度を見分ける解釈可能な機械学習モデル https://news.medxy.ai/vi/interpretable-periodontitis-severity-model-2/Medxy AIvi2026-11-06T02:33:55-08:00Mô hình machine learning có khả năng diễn giải để phân tầng mức độ nặng của viêm nha chu bằng các dấu ấn sinh học máu thường quy https://news.medxy.ai/interpretable-machine-learning-model-for-stratifying-periodontitis-severity-using-routine-blood-biomarkers/Medxy AIen2026-11-06T02:33:31-08:00Interpretable Machine Learning Model for Stratifying Periodontitis Severity Using Routine Blood Biomarkers https://news.medxy.ai/zh/outpatient-ecg-after-syncope/Medxy AIzh2026-11-06T02:32:49-08:00急诊晕厥后立即行门诊ECG监测的价值：ASPIRED试验带来的启示 https://news.medxy.ai/ja/outpatient-ecg-monitoring/Medxy AIja2026-11-06T02:32:28-08:00原因不明失神に対する即時外来ECGモニタリングを検証する：ASPIRED試験からの知見 https://news.medxy.ai/vi/ambulatory-ecg-after-syncope/Medxy AIvi2026-11-06T02:31:56-08:00Theo dõi ECG lưu động ngay sau ngất không rõ nguyên nhân: Kết quả từ thử nghiệm ASPIRED https://news.medxy.ai/evaluating-immediate-ambulatory-ecg-monitoring-for-unexplained-syncope-insights-from-the-aspired-trial/Medxy AIen2026-11-06T02:31:35-08:00Evaluating Immediate Ambulatory ECG Monitoring for Unexplained Syncope: Insights from the ASPIRED Trial https://news.medxy.ai/zh/cervical-lesion-resin-comparison/Medxy AIzh2026-11-05T03:58:41-08:00非龋性颈部病损中单色号与多色号流动树脂复合材料的临床表现及色彩匹配比较：一项18个月双盲随机试验 https://news.medxy.ai/ja/composite-restoration-comparison/Medxy AIja2026-11-05T03:58:19-08:00非う蝕性歯頸部病変に対する単色系と多色系フローブルコンポジットの臨床成績と色調適合性の比較：18か月二重盲検無作為化試験 https://news.medxy.ai/vi/flowable-composite-color-matching/Medxy AIvi2026-11-05T03:57:41-08:00So sánh hiệu quả lâm sàng và khả năng khớp màu giữa composite chảy một màu và nhiều màu trong tổn thương cổ răng không do sâu răng: thử nghiệm ngẫu nhiên mù đôi kéo dài 18 tháng https://news.medxy.ai/comparative-clinical-performance-and-color-matching-of-one-shade-vs-multi-shade-flowable-composites-in-non-carious-cervical-lesions-an-18-month-double-blind-randomized-trial/Medxy AIen2026-11-05T03:57:20-08:00Comparative Clinical Performance and Color Matching of One-Shade vs. Multi-Shade Flowable Composites in Non-Carious Cervical Lesions: An 18-Month Double-Blind Randomized Trial https://news.medxy.ai/zh/izalontamab-brengitecan-hr-postive-her2-negative-breast-cancer/Medxy AIzh2026-11-05T03:56:29-08:00Izalontamab brengitecan 用于既往多线治疗的 HR+/HER2- 乳腺癌：PANKU-Breast01 III 期临床试验 https://news.medxy.ai/ja/izalontamab-brengitecan-breast-cancer/Medxy AIja2026-11-05T03:56:05-08:00多治療歴 HR+/HER2- 乳癌における izalontamab brengitecan：中国 PANKU-Breast01 第 3 相試験からの知見 https://news.medxy.ai/vi/izalontamab-brengitecan-her2-negative-breast-cancer/Medxy AIvi2026-11-05T03:55:40-08:00Izalontamab brengitecan trong ung thư vú HR+/HER2- đã qua nhiều phác đồ điều trị: Thử nghiệm giai đoạn 3 PANKU-Breast01 https://news.medxy.ai/izalontamab-brengitecan-in-heavily-pretreated-hr-her2-breast-cancer-insights-from-the-panku-breast01-phase-3-trial-in-china/Medxy AIen2026-11-05T03:55:18-08:00Izalontamab Brengitecan in Heavily Pretreated HR+/HER2- Breast Cancer: Insights from the PANKU-Breast01 Phase 3 Trial in China https://news.medxy.ai/zh/long-term-zika-outcomes/Medxy AIzh2026-11-05T03:54:27-08:00Zika病毒相关小头畸形患儿的长期临床结局：来自生命最初五年的观察 https://news.medxy.ai/ja/long-term-zika-outcomes-2/Medxy AIja2026-11-05T03:54:06-08:00Zika関連小頭症の長期臨床転帰：生後5年間から見えた実態 https://news.medxy.ai/vi/zika-microcephaly-outcomes/Medxy AIvi2026-11-05T03:53:39-08:00Đầu nhỏ liên quan đến Zika: Kết cục lâm sàng dài hạn trong 5 năm đầu đời https://news.medxy.ai/long-term-clinical-outcomes-of-zika-related-microcephaly-insights-from-the-first-five-years-of-life/Medxy AIen2026-11-05T03:53:19-08:00Long-Term Clinical Outcomes of Zika-Related Microcephaly: Insights from the First Five Years of Life https://news.medxy.ai/zh/biologics-vs-dmards-psoriatic-arthritis/Medxy AIzh2026-11-05T03:52:36-08:00银屑病关节炎中生物制剂改良型抗风湿药的真实世界比较：来自模拟多中心试验的启示 https://news.medxy.ai/ja/biologic-dmards-psoriatic-arthritis/Medxy AIja2026-11-05T03:52:08-08:00乾癬性関節炎における生物学的DMARDsの実臨床有効性と継続性：模擬多施設試験からの知見 https://news.medxy.ai/vi/psoriatic-arthritis-biologic-dmards/Medxy AIvi2026-11-05T03:51:35-08:00Viêm khớp vảy nến: Hiệu quả thực tế và khả năng duy trì của các thuốc DMARD sinh học qua một thử nghiệm đa trung tâm mô phỏng https://news.medxy.ai/comparative-real-world-effectiveness-and-retention-of-biologic-dmards-in-psoriatic-arthritis-insights-from-an-emulated-multicentre-trial/Medxy AIen2026-11-05T03:51:13-08:00Comparative Real-World Effectiveness and Retention of Biologic DMARDs in Psoriatic Arthritis: Insights from an Emulated Multicentre Trial https://news.medxy.ai/zh/masld-liver-transplant-trends/Medxy AIzh2026-11-05T03:50:26-08:00MASLD在肝移植中的上升趋势与结局：早期识别和管理的启示 https://news.medxy.ai/ja/masld-liver-transplant-outcomes/Medxy AIja2026-11-05T03:50:04-08:00肝移植におけるMASLDの増加傾向と転帰：早期発見・管理への示唆 https://news.medxy.ai/vi/masld-liver-transplant-trends-2/Medxy AIvi2026-11-05T03:49:38-08:00Xu hướng gia tăng MASLD trong ghép gan: hàm ý cho phát hiện sớm và quản lý hiệu quả https://news.medxy.ai/rising-trends-and-outcomes-of-masld-in-liver-transplantation-implications-for-early-detection-and-management/Medxy AIen2026-11-05T03:49:17-08:00Rising Trends and Outcomes of MASLD in Liver Transplantation: Implications for Early Detection and Management https://news.medxy.ai/zh/post-mohs-postauricular-flap-complications/Medxy AIzh2026-11-05T03:48:37-08:00Mohs 手术后耳后插入皮瓣并发症：来自大样本回顾性研究的预测因素与结局 https://news.medxy.ai/ja/post-mohs-ear-flap-complications/Medxy AIja2026-11-05T03:48:18-08:00Mohs 手術後の耳後部 interpolated flap における合併症：大規模後ろ向き研究からみた予測因子と転帰 https://news.medxy.ai/vi/retroauricular-flap-complications/Medxy AIvi2026-11-05T03:47:53-08:00Yếu tố dự báo và kết cục biến chứng của vạt xen kẽ sau tai sau phẫu thuật Mohs: góc nhìn từ một nghiên cứu hồi cứu quy mô lớn https://news.medxy.ai/predictors-and-outcomes-of-complications-in-retroauricular-interpolated-flaps-following-mohs-surgery-insights-from-a-large-retrospective-study/Medxy AIen2026-11-05T03:47:32-08:00Predictors and Outcomes of Complications in Retroauricular Interpolated Flaps Following Mohs Surgery: Insights from a Large Retrospective Study https://news.medxy.ai/zh/conjoined-twin-separation-reconstruction/Medxy AIzh2026-11-05T03:46:45-08:00连体双胎分离与重建：一项三级儿科中心的解剖分类、手术策略与结局 https://news.medxy.ai/ja/conjoined-twin-separation-reconstruction-2/Medxy AIja2026-11-05T03:46:19-08:00连体双胎分离与重建的新进展：来自三级儿科中心的解剖分类、手术策略与结局 https://news.medxy.ai/vi/conjoined-twin-separation-reconstruction-surgery/Medxy AIvi2026-11-05T03:45:55-08:00Tách rời và tái tạo cho cặp song sinh dính liền: Phân loại giải phẫu, chiến lược phẫu thuật và kết quả tại một trung tâm nhi khoa tuyến cuối https://news.medxy.ai/conjoined-twin-separation-and-reconstruction-anatomical-classification-surgical-strategies-and-outcomes-from-a-tertiary-pediatric-center/Medxy AIen2026-11-05T03:45:30-08:00Conjoined Twin Separation and Reconstruction: Anatomical Classification, Surgical Strategies, and Outcomes from a Tertiary Pediatric Center https://news.medxy.ai/zh/trauma-informed-care-3/Medxy AIzh2026-11-05T03:44:41-08:00战时民用医院如何大规模开展创伤知情精神卫生服务：Unbroken 整合性心理创伤照护模式 https://news.medxy.ai/ja/trauma-informed-ukraine-mental-health/Medxy AIja2026-11-05T03:44:21-08:00戦時下ウクライナで広がるトラウマ・インフォームド精神医療――Unbroken Integrative Psycho-Trauma Care Modelの実践 https://news.medxy.ai/vi/unbroken-ukraine-war-mental-health/Medxy AIvi2026-11-05T03:43:53-08:00Unbroken: Mô hình chăm sóc tâm lý–chấn thương tích hợp cho sức khỏe tâm thần thời chiến tại Ukraine https://news.medxy.ai/the-unbroken-integrative-psycho-trauma-care-model-scaling-trauma-informed-mental-health-services-in-wartime-ukraine/Medxy AIen2026-11-05T03:43:31-08:00The Unbroken Integrative Psycho-Trauma Care Model: Scaling Trauma-Informed Mental Health Services in Wartime Ukraine https://news.medxy.ai/zh/pediatric-ecpr-survival-analysis/Medxy AIzh2026-11-05T03:42:52-08:00儿童院内心脏骤停后 ECPR 生存差异分析：风险标准化生存模型的构建与验证 https://news.medxy.ai/ja/survival-analysis-pediatric-ecpr/Medxy AIja2026-11-05T03:42:30-08:00小児施設内心停止後のECPRにおける生存の差異に関する分析：リスク標準化生存モデルの構築と検証 https://news.medxy.ai/vi/survival-analysis-in-pediatric-ecpr/Medxy AIvi2026-11-05T03:42:05-08:00Phân tích sự khác biệt về khả năng sống sót sau ngưng tim tại bệnh viện ở trẻ em được điều trị bằng ECPR https://news.medxy.ai/analyzing-variability-in-pediatric-ecpr-survival-after-in-hospital-cardiac-arrest-development-and-validation-of-a-risk-standardized-survival-model/Medxy AIen2026-11-05T03:41:43-08:00Analyzing Variability in Pediatric ECPR Survival After In-Hospital Cardiac Arrest: Development and Validation of a Risk-Standardized Survival Model https://news.medxy.ai/evaluating-blood-based-biomarkers-gfap-and-uch-l1-for-diagnosing-intracranial-injury-in-mild-traumatic-brain-injury-patients-in-the-emergency-department/Medxy AIen2026-11-05T03:41:00-08:00Evaluating Blood-Based Biomarkers GFAP and UCH-L1 for Diagnosing Intracranial Injury in Mild Traumatic Brain Injury Patients in the Emergency Department https://news.medxy.ai/zh/customized-pain-self-management/Medxy AIzh2026-11-05T03:40:17-08:00为慢性疼痛合并阿片类药物使用障碍患者定制疼痛自我管理：来自患者与临床医生的启示 https://news.medxy.ai/ja/customized-pain-self-management-plan/Medxy AIja2026-11-05T03:39:56-08:00慢性疼痛を合併するオピオイド使用障害患者に向けた、疼痛自己管理の個別化：患者および臨床医からの示唆 https://news.medxy.ai/vi/personalized-pain-management/Medxy AIvi2026-11-05T03:39:25-08:00Cá thể hóa tự quản lý đau cho bệnh nhân đau mạn tính và rối loạn sử dụng opioid: Góc nhìn từ bệnh nhân và bác sĩ lâm sàng https://news.medxy.ai/tailoring-pain-self-management-for-patients-with-chronic-pain-and-opioid-use-disorder-insights-from-patients-and-clinicians/Medxy AIen2026-11-05T03:39:03-08:00Tailoring Pain Self-Management for Patients with Chronic Pain and Opioid Use Disorder: Insights from Patients and Clinicians https://news.medxy.ai/zh/ebv-positive-lymphoproliferative-disease/Medxy AIzh2026-11-05T03:38:01-08:00揭示 CD7 CAR-T 后 EBV 阳性淋巴增殖性疾病：来自多组学与空间分析的启示 https://news.medxy.ai/ja/ebv-lymphoproliferative-disease/Medxy AIja2026-11-05T03:37:43-08:00CD7 CAR-T後のEBV陽性リンパ増殖性疾患を読み解く：マルチオミクスと空間プロファイリングから見えた病態 https://news.medxy.ai/vi/ebv-positive-lymphoproliferative-disorder/Medxy AIvi2026-11-05T03:37:21-08:00Giải mã rối loạn tăng sinh lympho dương tính với EBV sau CAR-T CD7: Góc nhìn từ đa omics và phân tích không gian https://news.medxy.ai/decoding-post-cd7-car-t-ebv-positive-lymphoproliferative-disorder-insights-from-multi-omics-and-spatial-profiling/Medxy AIen2026-11-05T03:37:00-08:00Decoding Post-CD7 CAR-T EBV-Positive Lymphoproliferative Disorder: Insights from Multi-Omics and Spatial Profiling https://news.medxy.ai/zh/ai-in-critical-care/Medxy AIzh2026-11-05T03:36:23-08:00十个寓言看 AI 在重症监护中的未来：在不确定性中前行 https://news.medxy.ai/ja/ai-in-intensive-care/Medxy AIja2026-11-05T03:35:59-08:00不確実性を読み解く：10の寓話で考える集中治療におけるAIの未来像 https://news.medxy.ai/vi/overcoming-uncertainty-ai-intensive-care/Medxy AIvi2026-11-05T03:35:34-08:00Vượt qua bất định: AI sẽ định hình tương lai của chăm sóc tích cực như thế nào qua mười ngụ ngôn https://news.medxy.ai/navigating-uncertainty-the-future-impact-of-artificial-intelligence-in-critical-care-through-ten-paradigms/Medxy AIen2026-11-05T03:35:09-08:00Navigating Uncertainty: The Future Impact of Artificial Intelligence in Critical Care through Ten Paradigms https://news.medxy.ai/zh/ranibizumab-reduced-diabetic-macular-edema/Medxy AIzh2026-11-05T03:30:10-08:00雷珠单抗持续给药下糖尿病黄斑水肿的消退过程 https://news.medxy.ai/ja/ranibizumab-diabetic-macular-edema/Medxy AIja2026-11-05T03:29:49-08:00Ranibizumab持続投与による糖尿病黄斑浮腫の消退過程：PDSでみるVEGF-A抑制の時間経過 https://news.medxy.ai/vi/ranibizumab-for-diabetic-macular-edema/Medxy AIvi2026-11-05T03:29:20-08:00Quá trình thoái lui phù hoàng điểm do đái tháo đường khi điều trị duy trì bằng Ranibizumab https://news.medxy.ai/time-course-of-resolution-of-diabetic-macular-edema-by-sustained-suppression-of-vegf-a-with-the-port-delivery-platform-with-ranibizumab/Medxy AIen2026-11-05T03:28:55-08:00Time Course of Resolution of Diabetic Macular Edema by Sustained Suppression of VEGF-A with the Port Delivery Platform with Ranibizumab https://news.medxy.ai/zh/social-vulnerability-sleep-apnea/Medxy AIzh2026-11-05T03:28:02-08:00社会脆弱性如何影响儿童阻塞性睡眠呼吸暂停结局：一项新研究 https://news.medxy.ai/ja/social-vulnerability-sleep-apnea-2/Medxy AIja2026-11-05T03:27:37-08:00社会的脆弱性が小児閉塞性睡眠時無呼吸症候群の転帰に及ぼす影響を読み解く https://news.medxy.ai/vi/social-vulnerability-for-sleep-apnea/Medxy AIvi2026-11-05T03:27:10-08:00Mức độ dễ bị tổn thương về mặt xã hội ảnh hưởng thế nào đến kết quả ở trẻ mắc chứng ngưng thở khi ngủ do tắc nghẽn https://news.medxy.ai/unveiling-the-impact-of-social-vulnerability-on-pediatric-obstructive-sleep-apnea-outcomes/Medxy AIen2026-11-05T03:26:46-08:00Unveiling the Impact of Social Vulnerability on Pediatric Obstructive Sleep Apnea Outcomes https://news.medxy.ai/zh/endoscopic-classification-predicts-fundoplication-integrity-reflux/Medxy AIzh2026-11-05T03:26:05-08:00一种新型内镜分型可预测抗反流手术后胃底折叠术完整性及病理性反流 https://news.medxy.ai/ja/predicting-reflux-recurrence/Medxy AIja2026-11-05T03:25:44-08:00抗逆流手術後の逆流再発を予測する新しい内視鏡分類：fundoplication完全性の評価 https://news.medxy.ai/vi/new-endoscopic-classification/Medxy AIvi2026-11-05T03:25:22-08:00Phân loại nội soi mới dự đoán tính toàn vẹn của Fundoplication và trào ngược bệnh lý sau phẫu thuật chống trào ngược https://news.medxy.ai/a-novel-endoscopic-classification-predicts-fundoplication-integrity-and-pathologic-reflux-after-antireflux-surgery/Medxy AIen2026-11-05T03:25:03-08:00A Novel Endoscopic Classification Predicts Fundoplication Integrity and Pathologic Reflux After Antireflux Surgery https://news.medxy.ai/zh/antidepressant-discontinuation-pregnancy/Medxy AIzh2026-11-05T03:24:25-08:00妊娠期停用抗抑郁药：对产妇精神卫生急症的影响 https://news.medxy.ai/ja/antidepressant-discontinuation-during-pregnancy/Medxy AIja2026-11-05T03:24:01-08:00妊娠期の抗うつ薬中止：妊産婦の精神衛生上の緊急事態への影響 https://news.medxy.ai/vi/antidepressant-discontinuation-for-pregnancy/Medxy AIvi2026-11-05T03:23:33-08:00Ngừng sử dụng thuốc chống trầm cảm trong thai kỳ: Tác động đối với các tình trạng khẩn cấp về sức khỏe tâm thần ở người mẹ https://news.medxy.ai/antidepressant-discontinuation-during-pregnancy-implications-for-maternal-mental-health-emergencies/Medxy AIen2026-11-05T03:23:09-08:00Antidepressant Discontinuation During Pregnancy: Implications for Maternal Mental Health Emergencies https://news.medxy.ai/zh/evolutionary-patterns-drug-induced-liver-injury/Medxy AIzh2026-11-05T03:22:28-08:00美国特异质性药物性肝损伤的演变格局与结局：来自20年DILIN前瞻性登记研究的启示 https://news.medxy.ai/ja/evolving-drug-induced-liver-injury/Medxy AIja2026-11-05T03:21:58-08:00米国における特異体質性薬物性肝障害の病因と転帰の変遷：20年にわたるDILIN前向きレジストリからの知見 https://news.medxy.ai/vi/personalized-drug-induced-liver-injury/Medxy AIvi2026-11-05T03:21:28-08:00Mô hình và kết cục biến đổi của tổn thương gan do thuốc mang tính cá thể hóa tại Hoa Kỳ: Góc nhìn từ cơ sở đăng ký tiến cứu DILIN trong 20 năm https://news.medxy.ai/evolving-patterns-and-outcomes-of-idiosyncratic-drug-induced-liver-injury-in-the-u-s-insights-from-the-20-year-dilin-prospective-registry/Medxy AIen2026-11-05T03:20:59-08:00Evolving Patterns and Outcomes of Idiosyncratic Drug-Induced Liver Injury in the U.S.: Insights from the 20-Year DILIN Prospective Registry https://news.medxy.ai/zh/water-pollution-psp-risk/Medxy AIzh2026-11-05T03:20:19-08:00水污染暴露与进行性核上性麻痹风险：英国生物样本库研究揭示环境关联 https://news.medxy.ai/ja/water-pollution-exposure/Medxy AIja2026-11-05T03:19:48-08:00水質汚染物質への環境曝露と進行性核上性麻痺リスク：UK Biobankからの知見 https://news.medxy.ai/vi/water-pollution-progressive-paralysis/Medxy AIvi2026-11-05T03:19:18-08:00Ô nhiễm nguồn nước và nguy cơ chứng liệt trên nhân tiến triển: Những phát hiện từ UK Biobank https://news.medxy.ai/environmental-exposure-to-water-pollutants-and-progressive-supranuclear-palsy-risk-insights-from-the-uk-biobank/Medxy AIen2026-11-05T03:18:53-08:00Environmental Exposure to Water Pollutants and Progressive Supranuclear Palsy Risk: Insights from the UK Biobank https://news.medxy.ai/zh/sglt2-inhibitor-safety/Medxy AIzh2026-11-05T03:18:13-08:00SGLT2抑制剂在2型糖尿病老年患者中的安全性：来自人群队列研究的证据 https://news.medxy.ai/ja/sglt2-safety-elderly-diabetes/Medxy AIja2026-11-05T03:17:51-08:00高齢2型糖尿病患者におけるSGLT2阻害薬の安全性：人口ベースコホート研究からの知見 https://news.medxy.ai/vi/sglt2i-safety-older-adults/Medxy AIvi2026-11-05T03:17:26-08:00Độ an toàn của SGLT2i ở người cao tuổi mắc đái tháo đường típ 2: Góc nhìn từ một nghiên cứu đoàn hệ dựa trên quần thể https://news.medxy.ai/safety-profile-of-sglt2-inhibitors-in-elderly-patients-with-type-2-diabetes-insights-from-a-population-based-cohort-study/Medxy AIen2026-11-05T03:17:03-08:00Safety Profile of SGLT2 Inhibitors in Elderly Patients with Type 2 Diabetes: Insights from a Population-Based Cohort Study https://news.medxy.ai/zh/cardiovascular-risk-prediction-4/Medxy AIzh2026-11-05T03:16:22-08:00联合评估 LDL-C、Lp(a) 和 hsCRP：多民族人群心血管风险预测更精准 https://news.medxy.ai/ja/cardiovascular-risk-prediction-3/Medxy AIja2026-11-05T03:15:57-08:00多民族集団におけるLDL-C・Lp(a)・hsCRP併用評価による心血管リスク予測の精緻化 https://news.medxy.ai/vi/enhanced-cardiovascular-risk-prediction/Medxy AIvi2026-11-05T03:15:30-08:00Tăng cường dự báo nguy cơ tim mạch nhờ phối hợp đánh giá LDL-C, Lp(a) và hsCRP ở quần thể đa sắc tộc https://news.medxy.ai/enhanced-cardiovascular-risk-prediction-through-combined-ldl-c-lpa-and-hscrp-assessment-in-a-multiethnic-population/Medxy AIen2026-11-05T03:15:11-08:00Enhanced Cardiovascular Risk Prediction Through Combined LDL-C, Lp(a), and hsCRP Assessment in a Multiethnic Population https://news.medxy.ai/zh/long-term-hip-arthroscopy-outcomes/Medxy AIzh2026-11-05T03:14:25-08:00青少年临界性髋关节发育不良合并股骨髋臼撞击行髋关节镜治疗的长期结局 https://news.medxy.ai/ja/long-term-hip-arthroscopy-outcomes-2/Medxy AIja2026-11-05T03:14:01-08:00境界型股関節形成不全を伴う思春期FAIに対する股関節鏡視下手術の長期成績 https://news.medxy.ai/vi/long-term-outcomes-hip-arthroscopy/Medxy AIvi2026-11-05T03:13:34-08:00Kết cục dài hạn của nội soi khớp háng trong điều trị chèn ép chỏm-xương ổ cối ở thanh thiếu niên có loạn sản khớp háng ranh giới https://news.medxy.ai/long-term-outcomes-of-hip-arthroscopy-for-femoroacetabular-impingement-in-adolescents-with-borderline-hip-dysplasia/Medxy AIen2026-11-05T03:13:14-08:00Long-Term Outcomes of Hip Arthroscopy for Femoroacetabular Impingement in Adolescents With Borderline Hip Dysplasia https://news.medxy.ai/zh/fall-risk-assessment/Medxy AIzh2026-11-05T03:12:34-08:00老年人跌倒风险如何评估？ReacStick 反应时与抑制控制的研究启示 https://news.medxy.ai/ja/elderly-fall-risk/Medxy AIja2026-11-05T03:12:11-08:00ReacStickでみる高齢者の転倒リスク：反応時間と抑制制御からの示唆 https://news.medxy.ai/vi/fall-risk-assessment-2/Medxy AIvi2026-11-05T03:11:44-08:00Đánh giá nguy cơ ngã ở người cao tuổi: Góc nhìn từ thời gian phản ứng và khả năng ức chế đáp ứng với ReacStick https://news.medxy.ai/evaluating-fall-risk-in-older-adults-insights-from-reaction-time-and-inhibitory-control-using-reacstick/Medxy AIen2026-11-05T03:11:23-08:00Evaluating Fall Risk in Older Adults: Insights from Reaction Time and Inhibitory Control Using ReacStick https://news.medxy.ai/zh/radiographic-root-fracture-periodontal-damage/Medxy AIzh2026-11-05T03:10:44-08:00影像学疑似牙骨质裂对牙周破坏的影响：一项大规模放射学研究的启示 https://news.medxy.ai/ja/cemental-tear-periodontal-destruction/Medxy AIja2026-11-05T03:10:20-08:00大規模X線研究が示す cemental tear 疑いと歯周組織破壊の関連 https://news.medxy.ai/vi/suspected-cementum-tears-periodontal-damage/Medxy AIvi2026-11-05T03:09:52-08:00Rách cementum nghi ngờ và tác động lên phá hủy nha chu: góc nhìn từ một nghiên cứu X-quang quy mô lớn https://news.medxy.ai/unveiling-the-impact-of-suspected-cemental-tears-on-periodontal-breakdown-insights-from-a-massive-radiographic-study/Medxy AIen2026-11-05T03:09:31-08:00Unveiling the Impact of Suspected Cemental Tears on Periodontal Breakdown: Insights from a Massive Radiographic Study https://news.medxy.ai/zh/tozorakimab-copd-exacerbation/Medxy AIzh2026-11-05T03:08:54-08:00Tozorakimab：降低COPD急性加重的潜力型单克隆抗体 https://news.medxy.ai/ja/tozorakimab-copd-treatment/Medxy AIja2026-11-05T03:08:32-08:00Tozorakimab、COPD増悪抑制に挑む有望なモノクローナル抗体 https://news.medxy.ai/vi/tozorakimab-copd-exacerbations/Medxy AIvi2026-11-05T03:08:10-08:00Tozorakimab: Kháng thể đơn dòng đầy triển vọng giúp giảm đợt cấp COPD https://news.medxy.ai/tozorakimab-a-promising-monoclonal-antibody-to-reduce-copd-exacerbations/Medxy AIen2026-11-05T03:07:49-08:00Tozorakimab: A Promising Monoclonal Antibody to Reduce COPD Exacerbations